In Silico Tools in Predictive Toxicology at Merck KGaA- An Interview with Philip Hewitt

Philip Hewitt
Contributor: Philip Hewitt
Posted: 11/16/2016

Pharma IQ:What are the major challenges that we face in predictive toxicology?Phil Hewitt:     The biggest challenge is acceptance from management.  I'm talking from experience at Merck, not globally. Because the assays you're developing to predict a human outcome haven't been proven, in most cases, relying on weak or

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Philip Hewitt
Contributor: Philip Hewitt
Posted: 11/16/2016

EVENTS OF INTEREST

Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018